Skip to main content
ChoA Pharmaceutical Co., LTD. logo

ChoA Pharmaceutical Co., LTD. — Investor Relations & Filings

Ticker · 034940 ISIN · KR7034940007 KO Manufacturing
Open in API
Filings indexed 119 across all filing types
Latest filing 2026-05-22 Proxy Solicitation & In…
Country KR South Korea
Listing KO 034940

About ChoA Pharmaceutical Co., LTD.

https://www.choa.co.kr/en/

ChoA Pharmaceutical Co., LTD., established in 1988, is a company engaged in the development, manufacturing, and sale of pharmaceutical products and health supplements. The company's portfolio comprises approximately 200 products, including over-the-counter (OTC) drugs, generic medications, and functional health foods. It offers a diverse range of formulations such as tablets, capsules, granules, ampoules, and a notable selection of liquid and drinkable products. ChoA Pharmaceutical primarily supplies pharmacies and maintains a global business presence, exporting its products to more than 20 countries. The company focuses on developing high-quality medicines and health-related products to contribute to public well-being.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 80% confidence The document is a formal notice resolving to convene a shareholders’ meeting (an extraordinary general meeting), including date, venue, record date and detailed agenda items. This corresponds to materials sent to shareholders to inform them of meeting proposals and solicit their votes. Under our taxonomy, that is a Proxy Solicitation & Information Statement (PSI).
2026-05-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 82% confidence The document is a brief regulatory announcement in Korean setting the record date (주주명부폐쇄기간 또는 기준일 설정) for a forthcoming extraordinary shareholders’ meeting. It provides dates and related statutory references but contains no financial data, report attachments, or in-depth analysis. This fits as a general regulatory filing disclosed on the exchange rather than a substantive financial or meeting material report. Therefore, it is classified under "Regulatory Filings (RNS)."
2026-05-22 Korean
주식병합결정
Share Issue/Capital Change Classification · 95% confidence The document is a corporate announcement detailing a stock consolidation (reverse share split): pre- and post-consolidation share counts, par values, schedule of shareholder meeting, effective dates, trading halt period, and related capital changes. This clearly falls under an announcement of a capital change (share consolidation), matching the Share Issue/Capital Change category (SHA).
2026-05-22 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is titled “분기보고서” (Quarterly Report) for the period January 1, 2026 to March 31, 2026 (1st quarter). It contains full financial statements (summary financials, consolidated statements, notes), business overview, management discussion, audit opinion, and detailed tables—consistent with a comprehensive interim/quarterly report rather than a brief earnings release or announcement. Therefore, it is classified as an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is titled “정기주주총회결과” (Annual General Meeting Results) and provides detailed voting outcomes for each agenda item, including approval rates, director elections, and constitutional amendments. This is a clear announcement of shareholder vote results at a general meeting, which corresponds to Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-03-23 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 95% confidence The document is a comprehensive 'Audit Report' (감사보고서) for JoongAng Pharmaceutical Co., Ltd. It includes the independent auditor's report, financial statements (balance sheet, income statement, cash flow, etc.), and detailed notes. It is not an Annual Report (10-K) as it focuses specifically on the audit and financial statements rather than the broader company activity report, and it is not an announcement (RPA) because it contains the full financial data. FY 2025
2026-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.